Pfizer PFE
NYSE PFE
$27.80 -0.32 (-1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pfizer (PFE) Net Income towards Common Stockholders (2009 - 2026)

Updated

Pfizer (PFE) reported Net Income towards Common Stockholders of -$248 million for Q2 2026, compared with $2.91 billion a year earlier.

Analysis

Pfizer (PFE) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 28, 2026, Pfizer's Net Income towards Common Stockholders came in at $4.33 billion, down 59.7% year-over-year; for FY2025, it came in at $7.77 billion, down 3.2% from FY2024.

  • Net Income towards Common Stockholders has a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
  • By year, Net Income towards Common Stockholders came in at $8.03 billion in FY2024 (+279.0%), $2.12 billion in FY2023 (-93.2%), $31.37 billion in FY2022 (+42.7%) and $21.98 billion in FY2021 (+140.0%).
  • Five-year quarterly Net Income towards Common Stockholders spans a low of -$3.37 billion in Q4 2023 and a high of $9.91 billion in Q2 2022.
  • The high point for year-over-year Net Income towards Common Stockholders in five years was Q3 2021 (growth of 454.5%); the low point was Q2 2024 (a decline of 98.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.69 billion (Q1 2026), -$1.65 billion (Q4 2025) and $3.54 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.61 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -248.00 Mn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 -248.00 Mn
Mar 29, 2026 2.69 Bn
Dec 31, 2025 -1.65 Bn
Sep 28, 2025 3.54 Bn
Jun 29, 2025 2.91 Bn
Mar 30, 2025 2.97 Bn
Dec 31, 2024 410.00 Mn
Sep 29, 2024 4.47 Bn
Jun 30, 2024 41.00 Mn
Mar 31, 2024 3.12 Bn
Dec 31, 2023 -3.37 Bn
Jul 2, 2023 2.33 Bn
Apr 2, 2023 5.54 Bn
Dec 31, 2022 5.00 Bn
Sep 30, 2022 -24.70 Bn
Jul 3, 2022 9.91 Bn
Apr 3, 2022 7.86 Bn
Dec 31, 2021 3.39 Bn
Oct 3, 2021 8.15 Bn
Jul 4, 2021 5.56 Bn
API Access

Pfizer Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PFE&period=max&api_key=YOUR_API_KEY